ADB-CHMINACA for sale online

ADB-CHMINACA (also known as MAB-CHMINACA, MA-CHMINACA, MABC) is an indole-based synthetic cannabinoid that has been sold as a designer drug and as an active ingredient in synthetic cannabis blends.

MAB-CHMINACA is a research chemical that was created in 2009 by Pfizer as an analgesic, which is synonymous with painkiller medications. In early 2015, it was identified in cannabinoid blends.

Chemistry of MAB-CHMINACA

“N-[(2S)-1-amino-3, 3-dimethyl-1-oxobutan-2-yl]-1-(cyclohexylmethyl) indazole-3-carboxamide” is the chemical formula for MAB-CHMINACA. This medication has a calculated molecular weight of 370.24 g/mol and a calculated purity of approximately equal to or better than 98% in its purest form. MAB-CHMINACA is a tidy solid with the chemical formula C 21 H 30 N 4 O 2. This is typically the form in which it is offered commercially. There are three main metabolites of MAB-CHMINACA: M7, M10, and M11. The medication’s stability in storage is known to last for at least two years, and 20°C is the recommended temperature. 


The drug is extensively used as a pain killer or an analgesic substance, which was the purpose it was initially produced. It acts on the peripheral and central nervous systems in order to mitigate pain caused by any reason. It is usually used as a sedative for muscle pain by people who are suffering from long-term illnesses or temporary illnesses that cause long-term pain in muscles. It causes a psychological impact on the well-being of people and is known to enhance their creative capabilities. People have also used it for recreational purposes.


It has a variety of both beneficial and detrimental effects. While the negative effects on the other hand can, in extreme cases, result in death, the beneficial results in people include a sense of well-being and pain relaxation. The overuse of synthetic cannabinoids has been linked to some recorded mortality instances. Among the adverse effects of the medication is dry mouth., reding of the eyes, and increased heart rate.

The drug also associates cognitive effects, as it can cause dysfunctional behavior in the body’s ability to perform normal functions by affecting the motor nerve functions. It can also cause short-term memory loss by impacting the hippocampus region in the brain. Drug impurities can also cause toxicity.

ADB-Chminaca Dose and Over-Dose

The dose of the drug ranges from 1mg – to 10mg, though it is a restricted drug and has to be administered only on a prescription issued by a physician. Although the higher dosage has the potential to produce the entire spectrum of effects, it can also have unfavorable side effects, such as severe injury or, in extreme cases, death.

Legal Status of MAB-CHMINACA

Some nations around the world forbid the manufacture, distribution, or possession of the drug, while others schedule or regulate its use.


There are no reviews yet.

Be the first to review “ADB-CHMINACA”

Your email address will not be published. Required fields are marked *